Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of Pregnancy

Gastroenterology

Volumn 133, Issue 2, 2007, Pages 507-516

  van Mil, Saskia W C ^a,b   Milona, Alexandra ^a   Dixon, Peter H ^a   Mullenbach, Roman ^a   Geenes, Victoria L ^a   Chambers, Jenny ^a   Shevchuk, Vasylyna ^a   Moore, Gudrun E ^c   Lammert, Frank ^d   Glantz, Anna G ^e   Mattsson, Lars Åke ^e   Whittaker, John ^f   Parker, Malcolm G ^a   White, Roger ^a   Williamson, Catherine ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY HOSPITAL BONN   (Germany)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; FARNESOID X RECEPTOR;

ARTICLE; CHOLESTASIS; CLINICAL FEATURE; CONTROLLED STUDY; ETHNICITY; EXON; FEMALE; FUNCTIONAL ASSESSMENT; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTRON; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 34547515667     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.05.015     Document Type: Article

References (46)

1. Abedin P., Weaver J.B., and Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 4 (1999) 35-37
2. Heinonen S., and Kirkinen P. Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 94 (1999) 189-193
3. Williamson C., Hems L.M., Goulis D.G., Walker I., Chambers J., Donaldson O., Swiet M., and Johnston D.G. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. Br J Obstet Gynecol 111 (2004) 676-681
4. Laatikainen T., and Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 50 (1977) 313-318
5. Laatikainen T., and Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22 (1984) 91-94
6. Glantz A., Marschall H.U., and Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40 (2004) 467-474
7. Reid R., Ivey K.J., Rencoret R.H., and Storey B. Fetal complications of obstetric cholestasis. Br Med J 1 (1976) 870-872
8. Reyes H. The enigma of intrahepatic cholestasis of pregnancy: lessons from Chile. Hepatology 2 (1982) 87-96
9. Rioseco A.J., Ivankovic M.B., Manzur A., Hamed F., Kato S.R., Parer J.T., and Germain A.M. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170 (1994) 890-895
10. Ropponen A., Sund R., Riikonen S., Ylikorkala O., and Aittomaki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43 (2006) 723-728
11. Dalen E., and Westerholm B. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters. Acta Med Scand 195 (1974) 459-463
12. Furhoff A.K. Itching in pregnancy. A 15-year follow-up study. Acta Med Scand 196 (1974) 403-410
13. Hirvioja M.L., and Kivinen S. Inheritance of intrahepatic cholestasis of pregnancy in one kindred. Clin Genet 43 (1993) 315-317
14. Holzbach R.T., Sivak D.A., and Braun W.E. Familial recurrent intrahepatic cholestasis of pregnancy: a genetic study providing evidence for transmission of a sex-limited, dominant trait. Gastroenterology 85 (1983) 175-179
15. Reyes H., Ribalta J., and Gonzalez-Ceron M. Idiopathic cholestasis of pregnancy in a large kindred. Gut 17 (1976) 709-713
16. Eloranta M.L., Heinonen S., Mononen T., and Saarikoski S. Risk of obstetric cholestasis in sisters of index patients. Clin Genet 60 (2001) 42-45
17. Pauli-Magnus C., Lang T., Meier Y., Zodan-Marin T., Jung D., Breymann C., Zimmermann R., Kenngott S., Beuers U., Reichel C., Kerb R., Penger A., Meier P.J., and Kullak-Ublick G.A. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 14 (2004) 91-102
18. Dixon P.H., Weerasekera N., Linton K.J., Donaldson O., Chambers J., Egginton E., Weaver J., Nelson-Piercy C., de S.M., Warnes G., Elias E., Higgins C.F., Johnston D.G., McCarthy M.I., and Williamson C. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 9 (2000) 1209-1217
19. Jacquemin E., Cresteil D., Manouvrier S., Boute O., and Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 353 (1999) 210-211
20. Mullenbach R., Linton K.J., Wiltshire S., Weerasekera N., Chambers J., Elias E., Higgins C.F., Johnston D.G., McCarthy M.I., and Williamson C. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 40 (2003) e70
21. Mullenbach R., Bennett A., Tetlow N., Patel N., Hamilton G., Cheng F., Chambers J., Howard R., Taylor-Robinson S.D., and Williamson C. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy. Gut 54 (2005) 829-834
22. Painter J.N., Savander M., Ropponen A., Nupponen N., Riikonen S., Ylikorkala O., Lehesjoki A.E., and Aittomaki K. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur J Hum Genet 13 (2005) 435-439
23. Deleuze J.F., Jacquemin E., Dubuisson C., Cresteil D., Dumont M., Erlinger S., Bernard O., and Hadchouel M. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 23 (1996) 904-908
24. Klomp L.W., Vargas J.C., van Mil S.W., Pawlikowska L., Strautnieks S.S., van Eijk M.J., Juijn J.A., Pabon-Pena C., Smith L.B., DeYoung J.A., Byrne J.A., Gombert J., van der B.G., Berger R., Jankowska I., Pawlowska J., Villa E., Knisely A.S., Thompson R.J., Freimer N.B., Houwen R.H., and Bull L.N. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 40 (2004) 27-38
25. Strautnieks S.S., Kagalwalla A.F., Tanner M.S., Knisely A.S., Bull L., Freimer N., Kocoshis S.A., Gardiner R.M., and Thompson R.J. Identification of a locus for progressive familial intrahepatic cholestasis PFIC2 on chromosome 2q24. Am J Hum Genet 61 (1997) 630-633
26. Makishima M., Okamoto A.Y., Repa J.J., Tu H., Learned R.M., Luk A., Hull M.V., Lustig K.D., Mangelsdorf D.J., and Shan B. Identification of a nuclear receptor for bile acids. Science 284 (1999) 1362-1365
27. Parks D.J., Blanchard S.G., Bledsoe R.K., Chandra G., Consler T.G., Kliewer S.A., Stimmel J.B., Willson T.M., Zavacki A.M., Moore D.D., and Lehmann J.M. Bile acids: natural ligands for an orphan nuclear receptor. Science 284 (1999) 1365-1368
28. Huber R.M., Murphy K., Miao B., Link J.R., Cunningham M.R., Rupar M.J., Gunyuzlu P.L., Haws T.F., Kassam A., Powell F., Hollis G.F., Young P.R., Mukherjee R., and Burn T.C. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene 290 (2002) 35-43
29. Zhang Y., Kast-Woelbern H.R., and Edwards P.A. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J Biol Chem 278 (2003) 104-110
30. Ananthanarayanan M., Balasubramanian N., Makishima M., Mangelsdorf D.J., and Suchy F.J. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem 276 (2001) 28857-28865
31. Huang L., Zhao A., Lew J.L., Zhang T., Hrywna Y., Thompson J.R., De P.N., Royo I., Blevins R.A., Pelaez F., Wright S.D., and Cui J. Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 278 (2003) 51085-51090
32. Barbier O., Torra I.P., Sirvent A., Claudel T., Blanquart C., Duran-Sandoval D., Kuipers F., Kosykh V., Fruchart J.C., and Staels B. FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124 (2003) 1926-1940
33. Echchgadda I., Song C.S., Roy A.K., and Chatterjee B. Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction by the vitamin D receptor. Mol Pharmacol 65 (2004) 720-729
34. Denson L.A., Sturm E., Echevarria W., Zimmerman T.L., Makishima M., Mangelsdorf D.J., and Karpen S.J. The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp. Gastroenterology 121 (2001) 140-147
35. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., Maloney P.R., Willson T.M., and Kliewer S.A. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6 (2000) 517-526
36. Li H., Chen F., Shang Q., Pan L., Shneider B.L., Chiang J.Y., Forman B.M., Ananthanarayanan M., Tint G.S., Salen G., and Xu G. FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. Am J Physiol Gastrointest Liver Physiol 288 (2005) G60-G66
37. Landrier J.F., Eloranta J.J., Vavricka S.R., and Kullak-Ublick G.A. The nuclear receptor for bile acids, FXR, transactivates the human organic solute transporter-alpha and -beta genes. Am J Physiol Gastrointest Liver Physiol 290 (2006) G476-G485
38. Wasmuth H.E., Glantz A., Keppeler H., Simon E., Bartz C., Rath W., Mattsson L.Å., Marschall H.U., and Lammert F. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut 56 (2007) 265-270
39. Belandia B., and Parker M.G. Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem 275 (2000) 30801-30805
40. Devarakonda S., Harp J.M., Kim Y., Ozyhar A., and Rastinejad F. Structure of the heterodimeric ecdysone receptor DNA-binding complex. EMBO J 22 (2003) 5827-5840
41. Metivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., and Gannon F. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 (2003) 751-763
42. Kreek M.J. Female sex steroids and cholestasis. Semin Liver Dis 7 (1987) 8-23
43. Reyes H., and Sjovall J. Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 32 (2000) 94-106
44. Sweeney T.R., Moser A.H., Shigenaga J.K., Grunfeld C., and Feingold K.R. Decreased nuclear hormone receptor expression in the livers of mice in late pregnancy. Am J Physiol Endocrinol Metab 290 (2006) E1313-E1320
45. Bergheim I., Harsch S., Mueller O., Schimmel S., Fritz P., and Stange E.F. Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers. J Lipid Res 47 (2006) 5250
46. Moschetta A., Bookout A.L., and Mangelsdorf D.J. Prevention of cholesterol gallstone disease by FXR agonists in a mouse model. Nat Med 10 (2004) 1352-1358